227 related articles for article (PubMed ID: 26608273)
1. Screening for cervical cancer in French Guiana: screening rates from 2006 to 2011.
Douine M; Roué T; Lelarge C; Adenis A; Thomas N; Nacher M
Bull Soc Pathol Exot; 2015 Dec; 108(5):355-9. PubMed ID: 26608273
[TBL] [Abstract][Full Text] [Related]
2. Cervical cancer incidence in French Guiana: South American.
Roue T; Nacher M; Fior A; Plenet J; Belliardo S; Gandolfo N; Deshayes JL; Laborde O; Carles G; Thomas N; Seve B; Patient G
Int J Gynecol Cancer; 2012 Jun; 22(5):850-3. PubMed ID: 22635032
[TBL] [Abstract][Full Text] [Related]
3. Predictive Factors of the Survival of Women With Invasive Breast Cancer in French Guiana: The Burden of Health Inequalities.
Roué T; Labbé S; Belliardo S; Plenet J; Douine M; Nacher M
Clin Breast Cancer; 2016 Aug; 16(4):e113-8. PubMed ID: 27036361
[TBL] [Abstract][Full Text] [Related]
4. About invasive cervical cancer: a French population based study between 1998 and 2010.
Lorin L; Bertaut A; Hudry D; Beltjens F; Roignot P; Bone-Lepinoy MC; Douvier S; Arveux P
Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():1-6. PubMed ID: 26004674
[TBL] [Abstract][Full Text] [Related]
5. [Organized cervical cancer screening for underpriviledged women].
Piana L; Leandri FX; Jacqueme B; Heid P; Corti J; Andrac-Meyer L; Sancho-Garnier H
Bull Cancer; 2007 May; 94(5):461-7. PubMed ID: 17535784
[TBL] [Abstract][Full Text] [Related]
6. Survival of patients with invasive cervical cancer in French Guiana, 2003-2008.
Douine M; Roue T; Fior A; Adenis A; Thomas N; Nacher M
Int J Gynaecol Obstet; 2014 May; 125(2):166-7. PubMed ID: 24598347
[No Abstract] [Full Text] [Related]
7. Prior high-risk HPV testing and Pap test results for 427 invasive cervical cancers in China's largest CAP-certified laboratory.
Zheng B; Li Z; Griffith CC; Yan S; Chen C; Ding X; Liang X; Yang H; Zhao C
Cancer Cytopathol; 2015 Jul; 123(7):428-34. PubMed ID: 25954852
[TBL] [Abstract][Full Text] [Related]
8. [Interval between two smear tests for cervical cancer screening and characteristics of women with a short interval: Study in the department of Isère].
Caporossi A; Olicard C; Seigneurin A; Garnier A
Rev Epidemiol Sante Publique; 2019 May; 67(3):143-147. PubMed ID: 30981595
[TBL] [Abstract][Full Text] [Related]
9. History of high-risk HPV and Pap test results in a large cohort of patients with invasive cervical carcinoma: experience from the largest women's hospital in China.
Tao X; Griffith CC; Zhou X; Wang Z; Yan Y; Li Z; Zhao C
Cancer Cytopathol; 2015 Jul; 123(7):421-7. PubMed ID: 25955972
[TBL] [Abstract][Full Text] [Related]
10. No increased risk for cervical cancer after a broader definition of a negative Pap smear.
Rebolj M; van Ballegooijen M; van Kemenade F; Looman C; Boer R; Habbema JD
Int J Cancer; 2008 Dec; 123(11):2632-5. PubMed ID: 18767046
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of an organized cervical cancer screening program in Korea: results from a cohort study.
Jun JK; Choi KS; Jung KW; Lee HY; Gapstur SM; Park EC; Yoo KY
Int J Cancer; 2009 Jan; 124(1):188-93. PubMed ID: 18785204
[TBL] [Abstract][Full Text] [Related]
12. Impact of implementing a nationwide cervical cancer screening program on female population coverage by Pap-tests in Estonia.
Veerus P; Arbyn M; Amati C; Paolo B;
Tumori; 2010; 96(4):524-8. PubMed ID: 20968130
[TBL] [Abstract][Full Text] [Related]
13. To what extent is women's economic situation associated with cancer screening uptake when nationwide screening exists? A study of breast and cervical cancer screening in France in 2010.
Menvielle G; Richard JB; Ringa V; Dray-Spira R; Beck F
Cancer Causes Control; 2014 Aug; 25(8):977-83. PubMed ID: 24842393
[TBL] [Abstract][Full Text] [Related]
14. [Cytological history of cases of invasive cervical cancer diagnosed in France in 2006].
Boulanger JC; Fauvet R; Urrutiaguer S; Drean Y; Sevestre H; Ganry O; Bergeron C; Gondry J
Gynecol Obstet Fertil; 2007 Sep; 35(9):764-71. PubMed ID: 17765001
[TBL] [Abstract][Full Text] [Related]
15. Gynaecological cancer in Caribbean women: data from the French population-based cancer registries of Martinique, Guadeloupe and French Guiana (2007-2014).
Joachim C; Véronique-Baudin J; Desroziers L; Chatignoux É; Belliardo S; Plenet J; Macni J; Ulric-Gervaise S; Peruvien J; Bhakkan-Mambir B; Deloumeaux J
BMC Cancer; 2020 Jul; 20(1):643. PubMed ID: 32650744
[TBL] [Abstract][Full Text] [Related]
16. Breast and cervical cancer screening disparities associated with disability severity.
Horner-Johnson W; Dobbertin K; Andresen EM; Iezzoni LI
Womens Health Issues; 2014; 24(1):e147-53. PubMed ID: 24439941
[TBL] [Abstract][Full Text] [Related]
17. Changes in cervical cancer incidence following the introduction of organized screening in Italy.
Serraino D; Gini A; Taborelli M; Ronco G; Giorgi-Rossi P; Zappa M; Crocetti E; Franzo A; Falcini F; Visioli CB; Stracci F; Zorzi M; Federico M; Michiara M; Fusco M; Ferretti S; Pannozzo F; Tisano F; Zanetti R; Zucchetto A; ;
Prev Med; 2015 Jun; 75():56-63. PubMed ID: 25818232
[TBL] [Abstract][Full Text] [Related]
18. Cervical morbidity in Alsace, France: results from a regional organized cervical cancer screening program.
Baldauf JJ; Fender M; Bergeron C; Marrer E; Velten M; Pradat P; Arbyn M
Eur J Cancer Prev; 2019 Jan; 28(1):33-39. PubMed ID: 29135538
[TBL] [Abstract][Full Text] [Related]
19. [Screening for cervical cancer in the county of Funen. Status of 25 years of development and experiences].
Hølund B; Grinsted P
Ugeskr Laeger; 2006 May; 168(22):2163-6. PubMed ID: 16768956
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the National Cervical Cancer Screening Programme in Singapore.
Jin AZ; Louange EC; Chow KY; Fock CW
Singapore Med J; 2013 Feb; 54(2):96-101. PubMed ID: 23462834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
